Predictive significance of STK17A in patients with gastric cancer and association with gastric cancer cell proliferation and migration

Wang,Zehua; Wang,Chenyi; Jiang,Bing-Hua; Shi,Litong; Lin,Shan; Wang,Lei; Liu,Ling-Zhi; Qiu,Jian-Ge; Qin,Yanru; Jia,Yongxu

doi:10.3892/or.2021.8070

Predictive significance of STK17A in patients with gastric cancer and association with gastric cancer cell proliferation and migration

Authors:
- Zehua Wang
- Chenyi Wang
- Bing-Hua Jiang
- Litong Shi
- Shan Lin
- Lei Wang
- Ling-Zhi Liu
- Jian-Ge Qiu
- Yanru Qin
- Yongxu Jia
View Affiliations

Affiliations: Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Department of General Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan 450052, P.R. China
Published online on: April 28, 2021 https://doi.org/10.3892/or.2021.8070
Article Number: 119
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric cancer (GC) is one of the most frequently diagnosed types of cancer worldwide, and exploring its potential therapeutic targets is particularly important for improving the prognosis of patients with GC. The aim of the present study was to investigate the association between serine/threonine kinase 17a (STK17A) expression and GC prognosis. STK17A expression was measured by quantitative real‑time PCR, western blotting and immunohistochemical staining. Standard stable transfection technology was also used to construct overexpression and knockdown cell lines. Wound healing, Transwell, Cell Counting Kit‑8 and colony formation assays, as well as other methods, were used to explore the function and underlying molecular mechanism of STK17A in GC. The results indicated that STK17A overexpression significantly promoted the proliferation and migration of GC cells. The clinical significance of STK17A in a cohort of 102 cases of GC was assessed by clinical correlation and Kaplan‑Meier analyses. Overexpression of STK17A was demonstrated to be associated with tumor invasion depth (P<0.001), lymph node metastasis (P<0.001) and poor prognosis in terms of 5‑year survival (P<0.001). In addition, Cox multivariate analysis revealed that STK17A expression was an independent risk factor for overall and progress‑free survival (P<0.001). Therefore, STK17A may be a valuable biomarker for the prognosis of patients with GC.

View Figures

View References

1	Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. Feb 4–2021.(Online ahead of print). View Article : Google Scholar : PubMed/NCBI
2	Cidon EU, Ellis SG, Inam Y, Adeleke S, Zarif S and Geldart T: Molecular targeted agents for gastric cancer: A step forward towards personalized therapy. Cancers (Basel). 5:64–91. 2013. View Article : Google Scholar : PubMed/NCBI
3	Steeg PS: Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer. 3:55–63. 2003. View Article : Google Scholar : PubMed/NCBI
4	Sanjo H, Kawai T and Akira S: DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J Biol Chem. 273:29066–29071. 1998. View Article : Google Scholar : PubMed/NCBI
5	Bialik S and Kimchi A: The death-associated protein kinases: Structure, function, and beyond. Annu Rev Biochem. 75:189–210. 2006. View Article : Google Scholar : PubMed/NCBI
6	Gao J, Liu D, Li J, Song Q and Wang Q: Effect of STK17A on the sensitivity of ovarian cancer cells to paclitaxel and carboplatin. Oncol Lett. 12:1107–1112. 2016. View Article : Google Scholar : PubMed/NCBI
7	Mao P, Hever MP, Niemaszyk LM, Haghkerdar JM, Yanco EG, Desai D, Beyrouthy MJ, Kerley-Hamilton JS, Freemantle SJ and Spinella MJ: Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells. J Biol Chem. 286:19381–19391. 2011. View Article : Google Scholar : PubMed/NCBI
8	Mao P, Hever-Jardine MP, Rahme GJ, Yang E, Tam J, Kodali A, Biswal B, Fadul CE, Gaur A, Israel MA and Spinella MJ: Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma. PLoS One. 8:e818032013. View Article : Google Scholar : PubMed/NCBI
9	Park Y, Kim W, Lee JM, Park J, Cho JK, Pang K, Lee J, Kim D, Park SW, Yang KM and Kim SJ: Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-β1 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4. Oncogene. 34:5037–5045. 2015. View Article : Google Scholar : PubMed/NCBI
10	Short SP, Thompson JJ, Bilotta AJ, Chen X, Revetta FL, Washington MK and Williams CS: Serine threonine kinase 17A maintains the epithelial state in colorectal cancer cells. Mol Cancer Res. 17:882–894. 2019. View Article : Google Scholar : PubMed/NCBI
11	Wei W and Liu C: Prognostic and predictive roles of microRNA-411 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the p53 signaling pathway in cervical cancer. Mol Med Rep. 21:267–281. 2020.PubMed/NCBI
12	Temmerman K, Simon B and Wilmanns M: Structural and functional diversity in the activity and regulation of DAPK-related protein kinases. FEBS J. 280:5533–5350. 2013. View Article : Google Scholar : PubMed/NCBI
13	Wang WJ, Kuo JC, Yao CC and Chen RH: DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J Cell Biol. 159:169–179. 2002. View Article : Google Scholar : PubMed/NCBI
14	Lin Y, Hupp TR and Stevens C: Death-associated protein kinase (DAPK) and signal transduction: Additional roles beyond cell death. FEBS J. 277:48–57. 2010. View Article : Google Scholar : PubMed/NCBI
15	Kiger AA, Baum B, Jones S, Jones MR, Coulson A, Echeverri C and Perrimon N: A functional genomic analysis of cell morphology using RNA interference. J Biol. 2:272003. View Article : Google Scholar : PubMed/NCBI
16	Neubueser D and Hipfner DR: Overlapping roles of Drosophila Drak and Rok kinases in epithelial tissue morphogenesis. Mol Biol Cell. 21:2869–2879. 2010. View Article : Google Scholar : PubMed/NCBI
17	Robertson F, Pinal N, Fichelson P and Pichaud F: Atonal and EGFR signalling orchestrate rok- and Drak-dependent adherens junction remodelling during ommatidia morphogenesis. Development. 139:3432–3441. 2012. View Article : Google Scholar : PubMed/NCBI
18	Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A and Olson MF: Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol. 3:339–345. 2001. View Article : Google Scholar : PubMed/NCBI
19	Gilmore AP: Anoikis. Cell Death Differ. 12 (Suppl 2):S1473–S1477. 2005. View Article : Google Scholar : PubMed/NCBI
20	Tang H, Liu YJ, Liu M and Li X: Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP. Anticancer Drugs. 18:633–639. 2007. View Article : Google Scholar : PubMed/NCBI
21	Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC cancer staging manual. 7th edition. New York NY: Springer; 2010
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Li Y, Nie CJ, Hu L, Qin Y, Liu HB, Zeng TT, Chen L, Fu L, Deng W, Chen SP, et al: Characterization of a novel mechanism of genomic instability involving the SEI1/SET/NM23H1 pathway in esophageal cancers. Cancer Res. 70:5695–5705. 2010. View Article : Google Scholar : PubMed/NCBI
24	Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428. 2009. View Article : Google Scholar : PubMed/NCBI
25	Inoue T, Umezawa A, Takenaka T, Suzuki H and Okada H: The contribution of epithelial-mesenchymal transition to renal fibrosis differs among kidney disease models. Kidney Int. 87:233–238. 2015. View Article : Google Scholar : PubMed/NCBI
26	Chen DH, Yu JW and Jiang BJ: Contactin 1: A potential therapeutic target and biomarker in gastric cancer. World J Gastroenterol. 21:9707–9716. 2015. View Article : Google Scholar : PubMed/NCBI
27	Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
28	Mesteri I, Schoppmann SF, Preusser M and Birner P: Overexpression of CMET is associated with signal transducer and activator of transcription 3 activation and diminished prognosis in oesophageal adenocarcinoma but not in squamous cell carcinoma. Eur J Cancer. 50:1354–1360. 2014. View Article : Google Scholar : PubMed/NCBI
29	Thomas A, Mahantshetty U, Kannan S, Deodhar K, Shrivastava SK, Kumar-Sinha C and Mulherkar R: Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease. Cancer Med. 2:836–648. 2013. View Article : Google Scholar : PubMed/NCBI
30	Cekirge HS, Peynircioglu B and Saatci I: Endovascular treatment of an ‘anterior cerebral artery’ aneurysm in a patient with ‘embryonic unfused middle cerebral artery’ anomaly: A case report. Neuroradiology. 47:690–694. 2005. View Article : Google Scholar : PubMed/NCBI